Cargando…
Identification of H7 as a novel peroxiredoxin I inhibitor to induce differentiation of leukemia cells
Identifying novel targets to enhance leukemia-cell differentiation is an urgent requirment. We have recently proposed that inhibiting the antioxidant enzyme peroxiredoxin I (Prdx I) may induce leukemia-cell differentiation. However, this concept remains to be confirmed. In this work, we identified H...
Autores principales: | Wei, Wei, Ma, Chunmin, Cao, Yang, Yang, Li, Huang, Zhimin, Qin, Dongjun, Chen, Yingyi, Liu, Chuanxu, Xia, Li, Wang, Tongdan, Lei, Hu, Yu, Yun, Huang, Min, Tong, Yin, Xu, Hanzhang, Gao, Fenghou, Zhang, Jian, Wu, Ying-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826176/ https://www.ncbi.nlm.nih.gov/pubmed/26716647 http://dx.doi.org/10.18632/oncotarget.6763 |
Ejemplares similares
-
CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
por: Qin, Dongjun, et al.
Publicado: (2016) -
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
por: Luo, Hao, et al.
Publicado: (2019) -
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
por: Shan, Huizhuang, et al.
Publicado: (2018) -
Peroxiredoxin-I Sustains Inflammation During Pancreatitis
por: Buckens, Hortense, et al.
Publicado: (2021) -
Peroxiredoxin, Senescence, and Cancer
por: Wu, Mengyao, et al.
Publicado: (2022)